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Schizophrenia is a complex mental disorder that displays behavioral deficits such as
decreased sensory gating, reduced social interaction and working memory deficits.
The neurodevelopmental model is one of the widely accepted hypotheses of the
etiology of schizophrenia. Subtle developmental abnormalities of the brain which stated
long before the onset of clinical symptoms are thought to lead to the emergence
of illness. Schizophrenia has strong genetic components but its underlying molecular
pathogenesis is still poorly understood. Genetic linkage and association studies have
identified several genes involved in neuronal migrations as candidate susceptibility
genes for schizophrenia, although their effect size is small. Recent progress in copy
number variation studies also has identified much higher risk loci such as 22q11.
Based on these genetic findings, we are now able to utilize genetically-defined animal
models. Here we summarize the results of neurodevelopmental and behavioral analysis
of genetically-defined animal models. Furthermore, animal model experiments have
demonstrated that embryonic and perinatal neurodevelopmental insults in neurogenesis
and neuronal migrations cause neuronal functional and behavioral deficits in affected
adult animals, which are similar to those of schizophrenic patients. However, these
findings do not establish causative relationship. Genetically-defined animal models are
a critical approach to explore the relationship between neuronal migration abnormalities
and behavioral abnormalities relevant to schizophrenia.
Keywords: schizophrenia, GABAergic interneuron, mouse models, Neuregulin1, DISC1, 22q11 deletion syndrome,
Dgcr8, Cxcr4
Introduction
Schizophrenia is a chronic psychiatric disorder with a strong genetic component. Twin studies
indicated that the heritability for schizophrenia is estimated to be 0.81 (Sullivan et al., 2012).
Most of genetic linkage studies failed to identify highly-shared risk alleles due to the complexity
of genetic architecture of schizophrenia except for DISC1 (Millar et al., 2000). Many combinations
of different gene variants cause genetic risk of schizophrenia. Genome-wide association studies
have identified many schizophrenia susceptibility candidate genes. Most of such common vari-
ants confer only slight increase in risk for schizophrenia (odds ratio < 1.2) (Ripke et al., 2013),
and often failed to be replicated. Some of them, Neuregulin1, ErbB4, and Reelin are involved in the
regulation of neuronal migration. On the other hand, rare and de novo chromosomal microdeletion
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or microduplication [copy number variations (CNVs)] have
been implicated in schizophrenia (Levinson et al., 2011; Rees
et al., 2014). Such CNVs are from thousands to millions
nucleotides and contain many genes and their odds ratios are
high (2∼20) compared with common variants. 22q11.2 deletion
syndrome (22q11DS) is the most frequent known genetic cause
of schizophrenia (Pulver et al., 1994). However, it remains to
be elucidated how combinations of these genetic variants play
pathogenic roles of schizophrenia.
Schizophrenia is believed to result from embryonic
developmental abnormalities not from neuronal degenerations
(Weinberger, 1987; O’Connell et al., 1997). Cytoarchitectural
abnormalities were reported in the entorhinal cortex (Jakob and
Beckmann, 1986; Arnold et al., 1991, 1997; Falkai et al., 2000) and
the subcortical white matters in schizophrenia (Akbarian et al.,
1993a,b, 1996). Decreased neuronal density in the superficial
white matter and increased density in the deep white matter
suggest neuronal migration defects in schizophrenia. However,
other studies failed to replicate these findings (Akil and Lewis,
1997; Krimer et al., 1997; Bernstein et al., 1998; Beasley et al.,
2002, 2009), suggesting these abnormalities might be too subtle
to be detected without special methods. Prior human brain
imaging studies also have indicated reduced cerebral volume,
ventricular enlargement, and reduced hippocampal volume in
schizophrenia (Shenton et al., 2001).
The development of the human cerebral cortex is simi-
lar to that in the mouse (Rakic, 2009; Hansen et al., 2013;
Ma et al., 2013), which enabled investigation of the func-
tions of schizophrenia susceptibility candidate genes in neu-
ronal developments. The mammalian cerebral cortex consists
mainly of excitatory glutametergic and inhibitory GABAergic
neurons. Glutamatergic neurons are generated from neural pro-
genitors in the dorsal forebrain (Glover et al., 2009; Rakic,
2009), whereas most of inhibitory neurons are thought to derive
from the ventral pallium: medial, lateral and caudate ganglionic
eminence (MGE, LGE, and CGE) (Hansen et al., 2013; Ma
et al., 2013). Two types of migration are observed in the cor-
tex. One is radial migration of glutamatergic neurons from the
underlying ventricular zone along the radial glial fiber, while
the other is tangential migration from the ventral forebrain of
GABAergic interneurons (Corbin et al., 2001; Marin and Ruben-
stein, 2003). However, the differences between the human and
mouse cortices are also reported. In the mouse, about 70%
of cortical interneurons generate from the MGE and ∼30%
are from the CGE (Miyoshi et al., 2010). In contrast, more
than half of interneurons derive from the CGE in the human
(Hansen et al., 2013). The human cortex showed a much higher
diversity in the interneuron types compared with that of the
rodents (Feldman and Peters, 1978). In spite of the limitations
caused by these differences, animal models are still valuable to
elucidate the roles of neuronal migration deficits in the pathogen-
esis of schizophrenia. Many genetically-modified animal mod-
els with construct validity and cell-specific gene modification
technique are available. The great advantage of rodent model
to study schizophrenia is that we can establish a causal rela-
tionship between genetic abnormalities, neuronal developments,
and behavioral abnormalities. Here we review a group of studies
using rodent models which give insights into the pathogenesis of
schizophrenia.
Developmental Neuronal Disruption Model
of Schizophrenia
Perinatal insult of neuronal development can cause anatomical
and behavioral deficits similar to human schizophrenic patients.
One of the examples is a gestational day 17 (GD17) methyla-
zoxymethanol acetate (MAM) administration rat model (Grace
and Moore, 1998; Flagstad et al., 2004; Gourevitch et al., 2004;
Paredes et al., 2006). MAM is a mitotic toxin and MAM admin-
istration specifically disrupts proliferating region. GD17 MAM
treatment results in specific subtle reductions in the volume of
prefrontal cortex (PFC) and hippocampus (HP), heterotopias in
the HP resulting from neuronal migration deficits (Le Pen et al.,
2006; Moore et al., 2006), which are characteristics of schizophre-
nia (Kovelman and Scheibel, 1984; Shenton et al., 2001; Heckers,
2004; Honea et al., 2005). GD17 MAM-treated rats also display
decreased density of parvalbumin (PV)-positive interneurons in
medial PFC and HP (Lodge et al., 2009). Interestingly, post-
mortem studies of human schizophrenia have shown decreased
expression of PV and the 67 KDa isoform of glutamic acid decar-
boxylase (GAD67), which is an enzyme responsible for GABA
synthesis, in PFC of schizophrenia subjects (Akbarian et al., 1995;
Volk et al., 2000; Hashimoto et al., 2003; Fung et al., 2010).
However, no difference is observed in the density of PV-positive
interneurons in schizophrenia (Hashimoto et al., 2003). PV-
positive interneurons are known to be indispensable for synchro-
nized firing of excitatory pyramidal neurons in gamma frequen-
cies (30–80Hz), which plays essential roles for cognitive func-
tions (Howard et al., 2003). Altered gamma oscillation activity
and cognitive deficits have been reported in schizophrenia (Cho
et al., 2006; Minzenberg et al., 2010). Consequently, PV-positive
interneuron deficits are thought to be the cause of impairments of
gamma oscillation and cognition in individuals with schizophre-
nia (Lewis et al., 2012). MAM-treated rats also show behavioral
deficits in prepulse inhibition (PPI), which reflects an inability to
filter out irrelevant sensory information, and working memory
task (Flagstad et al., 2005; Le Pen et al., 2006; Moore et al., 2006),
which are typical symptoms of schizophrenia in humans (Braff
and Geyer, 1990; Liddle andMorris, 1991; Goldman-Rakic, 1994;
Swerdlow et al., 1994; Nuechterlein et al., 2004). Furthermore,
electrophysiological studies have shown that enhanced activity of
ventral HP leads to dopaminergic neuronal activation in MAM-
treated rats (Lodge and Grace, 2007). Again, these altered hip-
pocampal activities are also observed in human schizophrenic
patients (Medoff et al., 2001; Schobel et al., 2009). These abnor-
malities can be normalized by administration of α5GABA A
receptor positive allosteric modulator, SH-053-2′F-R-CH3 (Gill
et al., 2011), suggesting the involvement of GABA in embryonic
MAM treatment-induced deficits. The MAM model provides a
direct evidence that subtle embryonic disruptions of neuronal
development result in behavioral alterations disorders, although
the etiology is absolutely different from that of schizophrenia in
humans.
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Neuregulin-ERBB Signaling
Neuregulins are a large family of epidermal growth factor
(EGF)-like proteins and play divergent roles both in neuronal
development and in the neuronal activity homeostasis in the
mature central nervous system. Several genetic linkage studies
have shown Neuregulin1 (NRG1) as a strong candidate gene
for schizophrenia (Badner and Gershon, 2002; Stefansson et al.,
2002; Lewis et al., 2003). Some GWASs also support the hypoth-
esis (Li et al., 2006; Munafo et al., 2006; Shi et al., 2009; Agim
et al., 2013), although it has not been confirmed by a recent
mega-analysis in which international consortia combined the
resources to maximize the sample size and identified more than
100 candidate genes for schizophrenia with high levels of sta-
tistical significance (Schizophrenia Working Group of the Psy-
chiztric Genomics Consortium, 2014). Most of schizophrenia-
associated single nucleotide polymorphisms (SNPs) in NRG1 are
localized in the 5′ and 3′ region of the gene. Some of them are
associated with the expression level of NRG1 (Law et al., 2006;
Weickert et al., 2012). A receptor of NRG1, ERBB4 is also asso-
ciated with schizophrenia (Benzel et al., 2007; Law et al., 2007;
Shi et al., 2009; Agim et al., 2013). It has been reported that
a rare chromosome micro-deletion in a schizophrenic patient
disrupts this gene, resulting in a truncated protein similar to
dominant-negative ERBB4 (Walsh et al., 2008).
Nrg1 generates six types and at least 30 isoforms owing
to multiple promoters and alternative splicing (Mei and Nave,
2014). Most pro-Nrg1 isoforms are transmembrane proteins and
N-terminal domains containing EGF-like domain are released
out of the cell after undergoing proteolytic processing except
for TypeIII Nrg1 (cysteine-rich-domain containing Nrg1 (CRD-
Nrg1)). This released mature Nrg1 activates ErbB receptor
tyrosine kinase such as ErbB2/ErbB3 heterodimer and ErbB4
homodimers. Nrg1 regulates migration of excitatory gluta-
matergic neurons and γ-aminobutyric acid (GABA)-producing
interneurons in the embryonic cortex. Nrg1 promotes the main-
tenance of radial glial cells in the cortex and induces elongation
of radial fiber, which are essential for the radial migration of cor-
tical excitatory neurons and cerebellar granule cells (Anton et al.,
1997; Rio et al., 1997). NRG1 is also critical for interneuronal tan-
gential migration (Flames et al., 2004; Li et al., 2012). ErbB4 is
expressed in interneuronal progenitors migrating from the MGE
to the cortex (Yau et al., 2003; Flames et al., 2004). Type III Nrg1 is
expressed in lateral ganglionic eminence, and Type I and II Nrg1
(immunoglobulin (Ig)-domain containing Nrg1 (Ig-Nrg1)) are
expressed in the embryonic cortex (Flames et al., 2004). Diffusible
Type I and II Nrg1 in the cortex are thought to attract ErbB4-
expressing interneurons along a permissive corridor of Type III
Nrg1 (Flames et al., 2004), although this model is challenged. In
another model, Nrg1, and Nrg3 have been proposed to be repel-
lants for migrating interneurons (Li et al., 2012). Loss of ErbB4
cuases embryonic lethality due to failed development of myocar-
dial trabeculae, which made it difficult to characterize the func-
tions of ErbB4 signaling in interneuronal migration (Gassmann
et al., 1995; Kramer et al., 1996). However, heart-rescued ErbB4
knockout mice with cardiac-specific ErbB4 transgene displayed
decreased number of GABAergic interneurons in the postnatal
cortex (Flames et al., 2004; Fisahn et al., 2009; Li et al., 2012),
which clearly showed the essential roles of Nrg1/ErbB4 signaling
in interneuronal migration.
Cell-specific gene modification techniques are now starting
to elucidate a link between Nrg1/ErbB4 signaling and patho-
physiology of schizophrenia. The gain and loss of function
of Nrg1/ErbB4 signaling were examined because postmortem
studies of schizophrenia reported both increased and decreased
NRG1/ERBB4 signaling in schizophrenic patients (Silberberg
et al., 2006; Law et al., 2007; Weickert et al., 2012; Joshi et al.,
2014). Transgenic mice overexpressing Type I Nrg1 showed
deficits in PPI and contextual fear conditioning, and hyperloco-
motion (Deakin et al., 2009, 2012; Yin et al., 2013; Luo et al.,
2014). If the overexpression of Nrg1 was switched off in adult
mice, its effects were reversible (Yin et al., 2013; Luo et al., 2014).
The influence of Nrg1 overexpression on neuronal development
remains to be elucidated. Nrg1 or ErbB4 heterozygous mice
and conditional knockout mice also displayed various behav-
ioral abnormalities: locomotor hyperactivity in open field (OF),
impairment in Prepulse inhibition (PPI), and fear conditioning
(Stefansson et al., 2002; Golub et al., 2004; Boucher et al., 2007;
O’Tuathaigh et al., 2007, 2010; Chen et al., 2008, 2010; Duffy
et al., 2008; Ehrlichman et al., 2009; Shamir et al., 2012; Del Pino
et al., 2013; Pei et al., 2014)(Table 1). Nrg1 heterozygous mice
and heart-rescued ErbB4 knockout (KO) mice showed decreased
number of cortical PV interneurons (Fisahn et al., 2009; Ned-
dens and Buonanno, 2010; Shamir et al., 2012; Pei et al., 2014)
(Table 1). However, PV interneuron-specific deletion of ErbB4
did not affect the number of cortical interneurons, which might
be due to the slow turnover of ErbB4 (Fazzari et al., 2010; Shamir
et al., 2012) (Table 1). A comparative behavioral analysis of ErbB4
KO and PV interneuron-specific ErbB4 KO mice demonstrated
that PV interneuron-specific deletion is sufficient for hyperactiv-
ity and deficits in PPI. The only difference is that ErbB4 KOmice
but not PV interneuron-specific ErbB4 KO mice exhibit reduced
anxiety-like behaviors and deficits in cued and contextual fear
conditioning (Shamir et al., 2012), which might be caused by
developmental disorders in ErbB4-deficient interneurons.
Disrupted-in Schizophrenia 1
The disrupted-in schizophrenia 1 (DISC1) gene was discovered at
the breakpoint of inherited balanced chromosomal translocation
in a Scottish family suffering from major depression, schizophre-
nia, and bipolar disorder (St Clair et al., 1990; Millar et al., 2000).
Following linkage analysis and association studies demonstrated
that DISC1 is significantly associated with schizophrenia, bipolar
disorder and major depression (Ekelund et al., 2001, 2004; Mac-
gregor et al., 2004; Hamshere et al., 2005; Hashimoto et al., 2006;
Liu et al., 2006; Thomson et al., 2014), although it has not been
confirmed by a recent mega-analysis of GWASs (Schizophre-
nia Working Group of the Psychiztric Genomics Consortium,
2014).
DISC1 is a scaffolding protein interacting with multiple pro-
teins: nuclear distribution gene E homolog-like 1 (NDEL1),
lissencephaly-1 (LIS1), phosphodiesterase 4B (PDE4B), glycogen
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TABLE 1 | Summary of mutant Nrg1/ErbB4 mouse models.




↑ → ND ND ND Boucher et al., 2007
↑ ↓ ND ND ND Stefansson et al., 2002
↑ ND Y maze Small ventricle ND O’Tuathaigh et al., 2007, 2010
Nrg1+/−
(TM)
→ → contextual FC ↓ ND PV/Gad67 in HC ↓ Pei et al., 2014
cued FC ↓ (western blotting)
Nrg1+/−
(TypeIII)
→ ↓ T-Maze↓ Enlarged lateral ventricle ND Chen et al., 2008
Nrg1+/− ↑ → ND ND ND Duffy et al., 2008
(EGF) → → Contextual FC ↓ ND ND Ehrlichman et al., 2009
ErbB4+/− ↑ → ND ND ND Stefansson et al., 2002
ErbB4f/−
(Nestin-Cre)
↓ ND Morri Water Maze
↑ (hetero)
ND ND Golub et al., 2004
ErbB4−/−
(heart-rescued)
↑ ↓ Contextual FC ↓
Cued FC ↓
ND Number of PV neurons ↓ Shamir et al., 2012
ErbB4f/f
(PV-Cre)
↑ ↓ Contextual FC→
Cued FC→
ND Number of PV neurons→ Shamir et al., 2012
ErbB4f/f
(PV-Cre)
ND ND Contextual FC ↓ ND ND Chen et al., 2010
ErbB4f/f
(Lhx6-Cre)
↑ ↓ Y-maze ↓ ND Number of PV neurons→ Del Pino et al., 2013
OF, open field, PPI:prepulse inhibition; FC, fear conditioning; TM, transmembrane region; PV, parvalbumin; HC, hippocampus; ND, not determined.
synthase kinase 3β (GSK3β) and DIX domain-containing 1
(DIXDC1) (Ozeki et al., 2003; Millar et al., 2005; Taya et al.,
2007; Mao et al., 2009). DISC1/DIXDC1 functions as a switch
between neuronal proliferation and migration. DISC1/DIXDC1
binds to GSK3β and inhibits its activity leading to prolifera-
tion of neural progenitors through the inhibition of β-catenin
degradation (Mao et al., 2009). CDK5 phosphorylation of DISC1
at S710 and DIXDC1 facilitates neuronal migration by disso-
ciating DISC1 from GSK3β and promoting its binding with
NDEL1 (Singh et al., 2010; Ishizuka et al., 2011). DISC1 vari-
ants associating with human brain structures and psychiatric
phenotypes have been reported to impair this switching mech-
anism (Singh et al., 2011). Furthermore, knockdown of DISC1
also impairs interneuronal tangential migrations (Steinecke et al.,
2012, 2014).
Two hypotheses are proposed on the pathophysiology of
the disruption of the DISC1 gene: that the Scottish mutation
decreases DISC1 expression and leads to haploinsufficiency; or
that the Scottish mutation results in production of carboxy-
terminal-truncated DISC1 (amino acids 1-598). This C-terminal
truncated DISC1 functions as a dominant negative protein, and
impairs microtubule dynamics by blocking interaction between
DISC1 and dynein complex (Kamiya et al., 2005). Dynein com-
plex contains LIS1 and NDEL1, and regulates coupling of the
nucleus and centrosome, which is indispensable for radial migra-
tion of cortical excitatory neurons (Sasaki et al., 2000). Knock-
down of DISC1 inhibits cortical neuronal cell migration (Kamiya
et al., 2005; Kubo et al., 2010).
Acute knockdown of DISC1 using RNAi leads to drastic
neuronal migration deficits. However, DISC1 KO mice
(Disc112-3/12-3) astonishingly showed almost normal cytoarchi-
tectures of the cerebral cortex and the HP (Kuroda et al., 2011),
whereas the number of PV-positive interneurons reduced in
female Disc112-3/12-3 mice (Nakai et al., 2014). The phenotypes
in the proliferation of neuronal progenitors have not been
examined in DISC1 KO mice, which will provide important
insight into the pathogenesis of DISC1 deficiency. Further-
more, Disc112-3/12-3 mice did not show schizophrenia-like
phenotype but exhibited lower anxiety and higher impulsivity
(Kuroda et al., 2011) (Table 2). Only female Disc112-3/12-3 mice
exhibited enhanced responsiveness to methamphetamine and
deficits in PPI (Kuroda et al., 2011). These milder phenotypes
of Disc112-3/12-3 mice might be explained by a compensation
mechanism after chronic loss of DISC1. N-nitroso-N-ethylurea
(ENU) mutagenesis was utilized to generate missense mutations
of Disc1. L100P mutant (Disc1L100P/L100P) mice showed reduced
brain volume, reduced number of cortical neurons, altered
distribution of cortical neurons, interneuonal migration deficits,
and schizophrenia-like behavioral abnormalities, although the
behavioral phenotypes were not confirmed by another group
due to the difference in the genetic background (Clapcote et al.,
2007; Lee et al., 2011, 2013; Shoji et al., 2012). 129S6/SvEv
25-bp deletion variant results in the production of a truncated
isoform of DISC1 (amino acids 1-542) (Koike et al., 2006).
C57BL/6J mice carrying the Disc1 gene from the 129S6/SvEv
strain (Disc1125 bp/125 bpmice) exhibited enlarged ventricle and
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working memory deficits (Koike et al., 2006; Juan et al., 2014).
Neuron-specific overexpression of the truncated DISC1 also
resulted in drastic phenotypes: enlarged lateral ventricle, reduced
number of PV-positive interneurons and schizophrenia-like
behavioral abnormalities (Hikida et al., 2007; Pletnikov et al.,
2008; Shen et al., 2008; Ayhan et al., 2011) (Table 2). Further-
more, a technique of inducible transgene expression enabled
a specific expression of truncated DISC1 during only prenatal
period, only postnatal period or both periods (Ayhan et al.,
2011). Prenatal expression only led to decreased brain volume
and decreased number of PV-positive interneurons. Enlarged
lateral ventricle seems to be affected by postnatal expression
of truncated DISC1. In contrast, enhanced responsiveness to
psychostimulant required prenatal and postnatal continuous
expression (Ayhan et al., 2011), which suggests that both
neurodevelopmental abnormality and neuronal functional
impairment caused by truncated DISC1 might be essential for
pathogenesis of schizophrenia.
22q11 Deletion Syndrome
22q11.2 deletion syndrome (22q11DS) is the most frequent
known genetic cause of schizophrenia (Pulver et al., 1994).
22q11DS accounts for about 1% of schizophrenia cases (Karayior-
gou et al., 1995; Manolio et al., 2009). Prior brain imaging stud-
ies of human 22q11 DS have indicated reduced cerebral volume,
ventricular enlargement and reduced hippocampal volume (Eliez
et al., 2000, 2001; Chow et al., 2002; Simon et al., 2005). All of
these brain anomalies have also been reported in schizophrenia
(Shenton et al., 2001). All of the genes except for one gene in
human 22q11.2 locus exist on mouse chromosome 16 (Puech
et al., 1997). This has facilitated the generation of mouse models
of 22q11 DS, which carry a hemizygous deletion of 22q11-related
region of mouse chromosome16 (Lindsay et al., 1999; Paylor and
Lindsay, 2006; Stark et al., 2008). These animal models show
schizophrenia-related behavioral abnormalities such as working
memory deficits, sensory information-processing deficits, and
enhanced responsiveness to psychostimulants (Paylor et al., 2001;
Stark et al., 2008; Earls et al., 2011; Kimoto et al., 2012), which
are recognized as major deficits of schizophrenia (Elvevag and
Goldberg, 2000; Green et al., 2000; Swerdlow et al., 2001). Ani-
mal models of 22q11DS showed reduced density of layer II–
IV projection neurons in a medial PFC (Meechan et al., 2009),
reduced volume of a perinatal HP dentate gyrus (Toritsuka et al.,
2013), delayed migration of hippocampal dentate neuronal pro-
genitors and cortical interneurons, and altered distribution of
PV-positive interneurons (Meechan et al., 2009, 2012; Toritsuka
et al., 2013), although it remains to be elucidated these deficits
in neurogenesis lead to excitatory/inhibitory imbalance or not.
Perinatal hippocampal DG and interneuronal migration abnor-
malities are caused by Cxcl12/Cxcr4 signaling deficits (Toritsuka
et al., 2013). Cxcl12/Cxcr4 signaling might play pivotal roles
in the pathogenesis of schizophrenia. Previous studies also sug-
gest a possible involvement of Cxcl12/Cxcr4 signaling in the
neurodevelopmental disorders of GD17 MAM-treated animal
model of schizophrenia (Paredes et al., 2006). The expression of
CXCL12 is decreased in olfactory neurons from sporadic cases
with schizophrenia compared with normal controls (Toritsuka
et al., 2013).
Among of genes deleted in 22q11DS, Dgcr8 is a promis-
ing candidate gene for schizophrenia-related phenotypes. Dgcr8
forms the microprocessor complex of microRNA (miRNA) with
Drosha, which is essential for miRNA production. Overex-
pression of Dgcr8 rescued interneuronal migration deficits of
22q11DS model mice, and the migration of hippocampal DG
and interneuronal progenitors were also affected inDgcr8+/−
mice (Toritsuka et al., 2013). These observations demonstrated
the important roles of Dgcr8 in the pathogenesis of 22q11DS.
miRNA–mediated regulation network fine tunes the balance
of signaling and confers robustness to the system (Herranz
and Cohen, 2010). miRNA-mediated regulation can buffer
increases or reductions in gene dosage (Staton et al., 2011).
Haplodeletion of Dgcr8 causes 20–70% reduction of a specific
subsets of mature miRNAs both in Dgcr8 heterozygous and
22q11DS model mice (Stark et al., 2008). Dgcr8 heterozygousity
might uncover the effects of 22q11 microdeletion through the
disruption of miRNA-mediated buffering effects. In mice, het-
erozygous deletion of Dgcr8 alone showed working memory
TABLE 2 | Summary of mutant Disc1 mouse models.




↑ ↓ Y-maze→ Enlarged lateral ventricle Number of PV neurons
↓
Hikida et al., 2007
BAC
DN-DISC1 tg
→ ND ND Enlarged lateral ventricle Number of PV neurons
↓
Shen et al., 2008
Inducible-CaMK
DN-DISC1 tg
↑ → ND Enlarged lateral ventricle Number of PV neurons
↓
Pletnikov et al., 2008; Ayhan
et al., 2011
Disc1 12−3/12−3 → ↓
(Female)
Y-maze→ Normal Number of PV neurons
↓ (female)
Kuroda et al., 2011; Nakai
et al., 2014
Disc1L100P/L100P ↑ ↓ T-maze ↓ Brain volume↓ Deficits in the
distribution of PV
neurons
Clapcote et al., 2007; Lee




→ → T-maze ↓ Enlarged lateral ventricle ND Koike et al., 2006; Juan
et al., 2014
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deficits, sensory information-processing deficits and some of
neurodevelopmental abnormalities such as reduced cortical neu-
ronal densities (Stark et al., 2008; Fenelon et al., 2011). The
behavioral abnormalities and neurodevelopmental disorders of
Dgcr8+/− mice are similar but some of them are milder than
those of 22q11DS model mice,(Stark et al., 2008; Meechan et al.,
2009; Fenelon et al., 2011), which might suggest that addi-
tional haplodeletion of other genes in 22q11-related regions
might be required for the complete reconstitution of pheno-
types of 22q11DS model mice. It remains to be elucidated
whether behavioral abnormalities of 22q11DS model mice are
directly caused by neuronal migration deficit and Cxcr4 signaling
defects.
Concluding Remarks
Elucidating the relationship between neurodevelopmental abnor-
malities and the pathogenesis of schizophrenia would be excep-
tionally difficult. In order to dissect the complex causal relations,
more sophisticated genetic manipulation would be required.
Combination of various techniques such as conditional knock-
out, inducible transgene expression and virus-mediated gene
delivery will enable cell type-specific and developmental stage-
specific knockout or rescue experiments. In the future com-
prehensive profile of neurodevelopmental deficits-behavioral
abnormalities will provide significant insights intomental disease
pathogenesis of all these neurodevelopmental genes.
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